nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—CYP2D6—Hydroxyurea—head and neck cancer	0.158	0.328	CbGbCtD
Morphine—CYP2C8—Fluorouracil—head and neck cancer	0.0944	0.196	CbGbCtD
Morphine—ABCB1—Vinblastine—head and neck cancer	0.0592	0.123	CbGbCtD
Morphine—CYP2D6—Vinblastine—head and neck cancer	0.0558	0.116	CbGbCtD
Morphine—ABCB1—Docetaxel—head and neck cancer	0.0488	0.102	CbGbCtD
Morphine—CYP3A4—Vinblastine—head and neck cancer	0.0355	0.0738	CbGbCtD
Morphine—CYP3A4—Docetaxel—head and neck cancer	0.0292	0.0609	CbGbCtD
Morphine—Blister—Hydroxyurea—head and neck cancer	0.00413	0.0133	CcSEcCtD
Morphine—Balance disorder—Fluorouracil—head and neck cancer	0.00392	0.0126	CcSEcCtD
Morphine—Tenderness—Hydroxyurea—head and neck cancer	0.00341	0.011	CcSEcCtD
Morphine—Bone pain—Vinblastine—head and neck cancer	0.00341	0.011	CcSEcCtD
Morphine—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00339	0.0109	CcSEcCtD
Morphine—Chest tightness—Docetaxel—head and neck cancer	0.0033	0.0106	CcSEcCtD
Morphine—Ulcer—Hydroxyurea—head and neck cancer	0.00315	0.0101	CcSEcCtD
Morphine—Nystagmus—Fluorouracil—head and neck cancer	0.003	0.00967	CcSEcCtD
Morphine—Blister—Fluorouracil—head and neck cancer	0.00297	0.00958	CcSEcCtD
Morphine—Menstruation irregular—Docetaxel—head and neck cancer	0.00279	0.009	CcSEcCtD
Morphine—Phlebitis—Vinblastine—head and neck cancer	0.00275	0.00886	CcSEcCtD
Morphine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00265	0.00854	CcSEcCtD
Morphine—Tenderness—Fluorouracil—head and neck cancer	0.00246	0.00791	CcSEcCtD
Morphine—Disorientation—Hydroxyurea—head and neck cancer	0.00242	0.00778	CcSEcCtD
Morphine—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00236	0.00761	CcSEcCtD
Morphine—Lacrimation increased—Fluorouracil—head and neck cancer	0.00233	0.00749	CcSEcCtD
Morphine—Intestinal obstruction—Docetaxel—head and neck cancer	0.00227	0.00731	CcSEcCtD
Morphine—Dysarthria—Fluorouracil—head and neck cancer	0.00227	0.0073	CcSEcCtD
Morphine—Ulcer—Fluorouracil—head and neck cancer	0.00227	0.0073	CcSEcCtD
Morphine—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00226	0.00729	CcSEcCtD
Morphine—Neuralgia—Docetaxel—head and neck cancer	0.00223	0.00717	CcSEcCtD
Morphine—Ileus—Docetaxel—head and neck cancer	0.00219	0.00704	CcSEcCtD
Morphine—Dermatitis contact—Fluorouracil—head and neck cancer	0.00212	0.00682	CcSEcCtD
Morphine—Coma—Fluorouracil—head and neck cancer	0.00196	0.00631	CcSEcCtD
Morphine—Breast disorder—Hydroxyurea—head and neck cancer	0.00195	0.00629	CcSEcCtD
Morphine—Rhinorrhoea—Docetaxel—head and neck cancer	0.00191	0.00615	CcSEcCtD
Morphine—Rigors—Docetaxel—head and neck cancer	0.00189	0.0061	CcSEcCtD
Morphine—Sepsis—Fluorouracil—head and neck cancer	0.00186	0.00599	CcSEcCtD
Morphine—Euphoric mood—Fluorouracil—head and neck cancer	0.00184	0.00593	CcSEcCtD
Morphine—Swelling—Fluorouracil—head and neck cancer	0.00176	0.00568	CcSEcCtD
Morphine—Amenorrhoea—Docetaxel—head and neck cancer	0.00176	0.00567	CcSEcCtD
Morphine—Chest discomfort—Docetaxel—head and neck cancer	0.00175	0.00563	CcSEcCtD
Morphine—Dysuria—Hydroxyurea—head and neck cancer	0.00175	0.00563	CcSEcCtD
Morphine—Disorientation—Fluorouracil—head and neck cancer	0.00174	0.0056	CcSEcCtD
Morphine—Lacrimation increased—Docetaxel—head and neck cancer	0.00168	0.00541	CcSEcCtD
Morphine—Oliguria—Docetaxel—head and neck cancer	0.00168	0.00541	CcSEcCtD
Morphine—Drug interaction—Docetaxel—head and neck cancer	0.00167	0.00537	CcSEcCtD
Morphine—Drowsiness—Hydroxyurea—head and neck cancer	0.00167	0.00537	CcSEcCtD
Morphine—Amnesia—Fluorouracil—head and neck cancer	0.00166	0.00533	CcSEcCtD
Morphine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00163	0.00526	CcSEcCtD
Morphine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00163	0.00524	CcSEcCtD
Morphine—Stomatitis—Hydroxyurea—head and neck cancer	0.00162	0.00523	CcSEcCtD
Morphine—Bone pain—Docetaxel—head and neck cancer	0.00161	0.0052	CcSEcCtD
Morphine—Lethargy—Fluorouracil—head and neck cancer	0.00159	0.00511	CcSEcCtD
Morphine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00158	0.00507	CcSEcCtD
Morphine—Respiratory failure—Docetaxel—head and neck cancer	0.00158	0.00507	CcSEcCtD
Morphine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00156	0.00501	CcSEcCtD
Morphine—Pulmonary embolism—Docetaxel—head and neck cancer	0.00155	0.00498	CcSEcCtD
Morphine—Hallucination—Hydroxyurea—head and neck cancer	0.00149	0.00479	CcSEcCtD
Morphine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00148	0.00477	CcSEcCtD
Morphine—Ataxia—Fluorouracil—head and neck cancer	0.00146	0.00471	CcSEcCtD
Morphine—Dry skin—Fluorouracil—head and neck cancer	0.00143	0.00459	CcSEcCtD
Morphine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00139	0.00448	CcSEcCtD
Morphine—Lightheadedness—Docetaxel—head and neck cancer	0.00138	0.00446	CcSEcCtD
Morphine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00138	0.00444	CcSEcCtD
Morphine—Angiopathy—Hydroxyurea—head and neck cancer	0.00136	0.00437	CcSEcCtD
Morphine—Dysphagia—Fluorouracil—head and neck cancer	0.00134	0.00433	CcSEcCtD
Morphine—Sepsis—Docetaxel—head and neck cancer	0.00134	0.00432	CcSEcCtD
Morphine—Chills—Hydroxyurea—head and neck cancer	0.00134	0.00432	CcSEcCtD
Morphine—Eosinophilia—Fluorouracil—head and neck cancer	0.00133	0.00429	CcSEcCtD
Morphine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00132	0.00427	CcSEcCtD
Morphine—Anaemia—Vinblastine—head and neck cancer	0.00132	0.00425	CcSEcCtD
Morphine—Phlebitis—Docetaxel—head and neck cancer	0.0013	0.0042	CcSEcCtD
Morphine—Erythema—Hydroxyurea—head and neck cancer	0.0013	0.00419	CcSEcCtD
Morphine—Malaise—Vinblastine—head and neck cancer	0.00129	0.00415	CcSEcCtD
Morphine—Vertigo—Vinblastine—head and neck cancer	0.00128	0.00413	CcSEcCtD
Morphine—Leukopenia—Vinblastine—head and neck cancer	0.00128	0.00412	CcSEcCtD
Morphine—Swelling—Docetaxel—head and neck cancer	0.00127	0.0041	CcSEcCtD
Morphine—Convulsion—Vinblastine—head and neck cancer	0.00124	0.00398	CcSEcCtD
Morphine—Hypertension—Vinblastine—head and neck cancer	0.00123	0.00397	CcSEcCtD
Morphine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00121	0.00389	CcSEcCtD
Morphine—Anaemia—Hydroxyurea—head and neck cancer	0.0012	0.00388	CcSEcCtD
Morphine—Discomfort—Vinblastine—head and neck cancer	0.0012	0.00387	CcSEcCtD
Morphine—Visual disturbance—Docetaxel—head and neck cancer	0.00118	0.00382	CcSEcCtD
Morphine—Atrial fibrillation—Docetaxel—head and neck cancer	0.00118	0.00382	CcSEcCtD
Morphine—Renal impairment—Docetaxel—head and neck cancer	0.00118	0.0038	CcSEcCtD
Morphine—Dermatitis bullous—Docetaxel—head and neck cancer	0.00117	0.00379	CcSEcCtD
Morphine—Malaise—Hydroxyurea—head and neck cancer	0.00117	0.00378	CcSEcCtD
Morphine—Stomatitis—Fluorouracil—head and neck cancer	0.00117	0.00376	CcSEcCtD
Morphine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00117	0.00375	CcSEcCtD
Morphine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00117	0.00375	CcSEcCtD
Morphine—Leukopenia—Hydroxyurea—head and neck cancer	0.00117	0.00375	CcSEcCtD
Morphine—Lethargy—Docetaxel—head and neck cancer	0.00115	0.00369	CcSEcCtD
Morphine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00114	0.00367	CcSEcCtD
Morphine—Convulsion—Hydroxyurea—head and neck cancer	0.00113	0.00363	CcSEcCtD
Morphine—Hyponatraemia—Docetaxel—head and neck cancer	0.00113	0.00363	CcSEcCtD
Morphine—Anorexia—Vinblastine—head and neck cancer	0.00111	0.00358	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0011	0.00355	CcSEcCtD
Morphine—Discomfort—Hydroxyurea—head and neck cancer	0.00109	0.00353	CcSEcCtD
Morphine—Rhinitis—Fluorouracil—head and neck cancer	0.00108	0.00348	CcSEcCtD
Morphine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00107	0.00345	CcSEcCtD
Morphine—Oedema—Hydroxyurea—head and neck cancer	0.00106	0.00342	CcSEcCtD
Morphine—Ataxia—Docetaxel—head and neck cancer	0.00106	0.0034	CcSEcCtD
Morphine—Infection—Hydroxyurea—head and neck cancer	0.00106	0.0034	CcSEcCtD
Morphine—Paraesthesia—Vinblastine—head and neck cancer	0.00105	0.00337	CcSEcCtD
Morphine—Dehydration—Docetaxel—head and neck cancer	0.00104	0.00336	CcSEcCtD
Morphine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00104	0.00336	CcSEcCtD
Morphine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00104	0.00335	CcSEcCtD
Morphine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00104	0.00334	CcSEcCtD
Morphine—Skin disorder—Hydroxyurea—head and neck cancer	0.00103	0.00332	CcSEcCtD
Morphine—Dry skin—Docetaxel—head and neck cancer	0.00103	0.00332	CcSEcCtD
Morphine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00103	0.0033	CcSEcCtD
Morphine—Abdominal pain upper—Docetaxel—head and neck cancer	0.00103	0.0033	CcSEcCtD
Morphine—Breast disorder—Docetaxel—head and neck cancer	0.00101	0.00327	CcSEcCtD
Morphine—Anorexia—Hydroxyurea—head and neck cancer	0.00101	0.00326	CcSEcCtD
Morphine—Decreased appetite—Vinblastine—head and neck cancer	0.00101	0.00326	CcSEcCtD
Morphine—Cramp muscle—Docetaxel—head and neck cancer	0.00101	0.00326	CcSEcCtD
Morphine—Nasopharyngitis—Docetaxel—head and neck cancer	0.001	0.00323	CcSEcCtD
Morphine—Pain—Vinblastine—head and neck cancer	0.000996	0.00321	CcSEcCtD
Morphine—Constipation—Vinblastine—head and neck cancer	0.000996	0.00321	CcSEcCtD
Morphine—Dysphagia—Docetaxel—head and neck cancer	0.000971	0.00313	CcSEcCtD
Morphine—Feeling abnormal—Vinblastine—head and neck cancer	0.00096	0.00309	CcSEcCtD
Morphine—Bronchospasm—Docetaxel—head and neck cancer	0.000955	0.00308	CcSEcCtD
Morphine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000953	0.00307	CcSEcCtD
Morphine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000947	0.00305	CcSEcCtD
Morphine—Somnolence—Hydroxyurea—head and neck cancer	0.000944	0.00304	CcSEcCtD
Morphine—Erythema—Fluorouracil—head and neck cancer	0.000937	0.00302	CcSEcCtD
Morphine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000935	0.00301	CcSEcCtD
Morphine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000923	0.00298	CcSEcCtD
Morphine—Abdominal pain—Vinblastine—head and neck cancer	0.000921	0.00297	CcSEcCtD
Morphine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000917	0.00295	CcSEcCtD
Morphine—Fatigue—Hydroxyurea—head and neck cancer	0.000916	0.00295	CcSEcCtD
Morphine—Pain—Hydroxyurea—head and neck cancer	0.000908	0.00293	CcSEcCtD
Morphine—Constipation—Hydroxyurea—head and neck cancer	0.000908	0.00293	CcSEcCtD
Morphine—Vision blurred—Fluorouracil—head and neck cancer	0.000883	0.00284	CcSEcCtD
Morphine—Weight decreased—Docetaxel—head and neck cancer	0.000878	0.00283	CcSEcCtD
Morphine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000875	0.00282	CcSEcCtD
Morphine—Anaemia—Fluorouracil—head and neck cancer	0.000866	0.00279	CcSEcCtD
Morphine—Hypersensitivity—Vinblastine—head and neck cancer	0.000858	0.00276	CcSEcCtD
Morphine—Renal failure—Docetaxel—head and neck cancer	0.000851	0.00274	CcSEcCtD
Morphine—Stomatitis—Docetaxel—head and neck cancer	0.000844	0.00272	CcSEcCtD
Morphine—Conjunctivitis—Docetaxel—head and neck cancer	0.000841	0.00271	CcSEcCtD
Morphine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00084	0.00271	CcSEcCtD
Morphine—Leukopenia—Fluorouracil—head and neck cancer	0.000839	0.0027	CcSEcCtD
Morphine—Asthenia—Vinblastine—head and neck cancer	0.000836	0.00269	CcSEcCtD
Morphine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000818	0.00264	CcSEcCtD
Morphine—Convulsion—Fluorouracil—head and neck cancer	0.000812	0.00262	CcSEcCtD
Morphine—Chest pain—Fluorouracil—head and neck cancer	0.000798	0.00257	CcSEcCtD
Morphine—Diarrhoea—Vinblastine—head and neck cancer	0.000797	0.00257	CcSEcCtD
Morphine—Discomfort—Fluorouracil—head and neck cancer	0.000788	0.00254	CcSEcCtD
Morphine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000783	0.00252	CcSEcCtD
Morphine—Rhinitis—Docetaxel—head and neck cancer	0.000779	0.00251	CcSEcCtD
Morphine—Hepatitis—Docetaxel—head and neck cancer	0.000777	0.0025	CcSEcCtD
Morphine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000773	0.00249	CcSEcCtD
Morphine—Confusional state—Fluorouracil—head and neck cancer	0.000771	0.00248	CcSEcCtD
Morphine—Dizziness—Vinblastine—head and neck cancer	0.00077	0.00248	CcSEcCtD
Morphine—Urinary tract disorder—Docetaxel—head and neck cancer	0.000767	0.00247	CcSEcCtD
Morphine—Oedema peripheral—Docetaxel—head and neck cancer	0.000765	0.00247	CcSEcCtD
Morphine—Oedema—Fluorouracil—head and neck cancer	0.000765	0.00246	CcSEcCtD
Morphine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000765	0.00246	CcSEcCtD
Morphine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000763	0.00246	CcSEcCtD
Morphine—Asthenia—Hydroxyurea—head and neck cancer	0.000762	0.00246	CcSEcCtD
Morphine—Urethral disorder—Docetaxel—head and neck cancer	0.000762	0.00245	CcSEcCtD
Morphine—Infection—Fluorouracil—head and neck cancer	0.00076	0.00245	CcSEcCtD
Morphine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00075	0.00242	CcSEcCtD
Morphine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000749	0.00241	CcSEcCtD
Morphine—Visual impairment—Docetaxel—head and neck cancer	0.000749	0.00241	CcSEcCtD
Morphine—Tachycardia—Fluorouracil—head and neck cancer	0.000746	0.0024	CcSEcCtD
Morphine—Vomiting—Vinblastine—head and neck cancer	0.000741	0.00239	CcSEcCtD
Morphine—Headache—Vinblastine—head and neck cancer	0.00073	0.00235	CcSEcCtD
Morphine—Anorexia—Fluorouracil—head and neck cancer	0.000729	0.00235	CcSEcCtD
Morphine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000727	0.00234	CcSEcCtD
Morphine—Eye disorder—Docetaxel—head and neck cancer	0.000726	0.00234	CcSEcCtD
Morphine—Flushing—Docetaxel—head and neck cancer	0.000721	0.00232	CcSEcCtD
Morphine—Hypotension—Fluorouracil—head and neck cancer	0.000715	0.0023	CcSEcCtD
Morphine—Angiopathy—Docetaxel—head and neck cancer	0.000705	0.00227	CcSEcCtD
Morphine—Dizziness—Hydroxyurea—head and neck cancer	0.000703	0.00226	CcSEcCtD
Morphine—Mediastinal disorder—Docetaxel—head and neck cancer	0.0007	0.00226	CcSEcCtD
Morphine—Chills—Docetaxel—head and neck cancer	0.000697	0.00225	CcSEcCtD
Morphine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000697	0.00224	CcSEcCtD
Morphine—Nausea—Vinblastine—head and neck cancer	0.000692	0.00223	CcSEcCtD
Morphine—Insomnia—Fluorouracil—head and neck cancer	0.000692	0.00223	CcSEcCtD
Morphine—Paraesthesia—Fluorouracil—head and neck cancer	0.000687	0.00221	CcSEcCtD
Morphine—Dyspnoea—Fluorouracil—head and neck cancer	0.000682	0.0022	CcSEcCtD
Morphine—Mental disorder—Docetaxel—head and neck cancer	0.000681	0.00219	CcSEcCtD
Morphine—Somnolence—Fluorouracil—head and neck cancer	0.00068	0.00219	CcSEcCtD
Morphine—Erythema—Docetaxel—head and neck cancer	0.000676	0.00218	CcSEcCtD
Morphine—Malnutrition—Docetaxel—head and neck cancer	0.000676	0.00218	CcSEcCtD
Morphine—Vomiting—Hydroxyurea—head and neck cancer	0.000675	0.00218	CcSEcCtD
Morphine—Dyspepsia—Fluorouracil—head and neck cancer	0.000673	0.00217	CcSEcCtD
Morphine—Rash—Hydroxyurea—head and neck cancer	0.00067	0.00216	CcSEcCtD
Morphine—Dermatitis—Hydroxyurea—head and neck cancer	0.000669	0.00216	CcSEcCtD
Morphine—Headache—Hydroxyurea—head and neck cancer	0.000666	0.00214	CcSEcCtD
Morphine—Decreased appetite—Fluorouracil—head and neck cancer	0.000665	0.00214	CcSEcCtD
Morphine—Dysgeusia—Docetaxel—head and neck cancer	0.000662	0.00213	CcSEcCtD
Morphine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00066	0.00213	CcSEcCtD
Morphine—Back pain—Docetaxel—head and neck cancer	0.000654	0.00211	CcSEcCtD
Morphine—Pain—Fluorouracil—head and neck cancer	0.000654	0.00211	CcSEcCtD
Morphine—Muscle spasms—Docetaxel—head and neck cancer	0.00065	0.00209	CcSEcCtD
Morphine—Nausea—Hydroxyurea—head and neck cancer	0.000631	0.00203	CcSEcCtD
Morphine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00063	0.00203	CcSEcCtD
Morphine—Anaemia—Docetaxel—head and neck cancer	0.000625	0.00201	CcSEcCtD
Morphine—Urticaria—Fluorouracil—head and neck cancer	0.000607	0.00196	CcSEcCtD
Morphine—Syncope—Docetaxel—head and neck cancer	0.000606	0.00195	CcSEcCtD
Morphine—Leukopenia—Docetaxel—head and neck cancer	0.000605	0.00195	CcSEcCtD
Morphine—Body temperature increased—Fluorouracil—head and neck cancer	0.000604	0.00195	CcSEcCtD
Morphine—Palpitations—Docetaxel—head and neck cancer	0.000598	0.00193	CcSEcCtD
Morphine—Loss of consciousness—Docetaxel—head and neck cancer	0.000594	0.00191	CcSEcCtD
Morphine—Cough—Docetaxel—head and neck cancer	0.00059	0.0019	CcSEcCtD
Morphine—Convulsion—Docetaxel—head and neck cancer	0.000586	0.00189	CcSEcCtD
Morphine—Hypertension—Docetaxel—head and neck cancer	0.000584	0.00188	CcSEcCtD
Morphine—Chest pain—Docetaxel—head and neck cancer	0.000576	0.00185	CcSEcCtD
Morphine—Arthralgia—Docetaxel—head and neck cancer	0.000576	0.00185	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000572	0.00184	CcSEcCtD
Morphine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000563	0.00181	CcSEcCtD
Morphine—Dry mouth—Docetaxel—head and neck cancer	0.000563	0.00181	CcSEcCtD
Morphine—Confusional state—Docetaxel—head and neck cancer	0.000556	0.00179	CcSEcCtD
Morphine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000552	0.00178	CcSEcCtD
Morphine—Oedema—Docetaxel—head and neck cancer	0.000552	0.00178	CcSEcCtD
Morphine—Infection—Docetaxel—head and neck cancer	0.000548	0.00177	CcSEcCtD
Morphine—Shock—Docetaxel—head and neck cancer	0.000543	0.00175	CcSEcCtD
Morphine—Nervous system disorder—Docetaxel—head and neck cancer	0.000541	0.00174	CcSEcCtD
Morphine—Pruritus—Fluorouracil—head and neck cancer	0.000541	0.00174	CcSEcCtD
Morphine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00054	0.00174	CcSEcCtD
Morphine—Tachycardia—Docetaxel—head and neck cancer	0.000539	0.00174	CcSEcCtD
Morphine—Skin disorder—Docetaxel—head and neck cancer	0.000536	0.00173	CcSEcCtD
Morphine—Anorexia—Docetaxel—head and neck cancer	0.000526	0.00169	CcSEcCtD
Morphine—Diarrhoea—Fluorouracil—head and neck cancer	0.000523	0.00169	CcSEcCtD
Morphine—Hypotension—Docetaxel—head and neck cancer	0.000516	0.00166	CcSEcCtD
Morphine—Dizziness—Fluorouracil—head and neck cancer	0.000506	0.00163	CcSEcCtD
Morphine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000503	0.00162	CcSEcCtD
Morphine—Insomnia—Docetaxel—head and neck cancer	0.000499	0.00161	CcSEcCtD
Morphine—Paraesthesia—Docetaxel—head and neck cancer	0.000496	0.0016	CcSEcCtD
Morphine—Dyspnoea—Docetaxel—head and neck cancer	0.000492	0.00159	CcSEcCtD
Morphine—Somnolence—Docetaxel—head and neck cancer	0.000491	0.00158	CcSEcCtD
Morphine—Vomiting—Fluorouracil—head and neck cancer	0.000486	0.00157	CcSEcCtD
Morphine—Dyspepsia—Docetaxel—head and neck cancer	0.000486	0.00157	CcSEcCtD
Morphine—Rash—Fluorouracil—head and neck cancer	0.000482	0.00155	CcSEcCtD
Morphine—Dermatitis—Fluorouracil—head and neck cancer	0.000482	0.00155	CcSEcCtD
Morphine—Decreased appetite—Docetaxel—head and neck cancer	0.00048	0.00155	CcSEcCtD
Morphine—Headache—Fluorouracil—head and neck cancer	0.000479	0.00154	CcSEcCtD
Morphine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000476	0.00154	CcSEcCtD
Morphine—Fatigue—Docetaxel—head and neck cancer	0.000476	0.00153	CcSEcCtD
Morphine—Pain—Docetaxel—head and neck cancer	0.000472	0.00152	CcSEcCtD
Morphine—Constipation—Docetaxel—head and neck cancer	0.000472	0.00152	CcSEcCtD
Morphine—Feeling abnormal—Docetaxel—head and neck cancer	0.000455	0.00147	CcSEcCtD
Morphine—Nausea—Fluorouracil—head and neck cancer	0.000454	0.00146	CcSEcCtD
Morphine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000451	0.00145	CcSEcCtD
Morphine—Body temperature increased—Docetaxel—head and neck cancer	0.000436	0.00141	CcSEcCtD
Morphine—Abdominal pain—Docetaxel—head and neck cancer	0.000436	0.00141	CcSEcCtD
Morphine—Hypersensitivity—Docetaxel—head and neck cancer	0.000407	0.00131	CcSEcCtD
Morphine—Asthenia—Docetaxel—head and neck cancer	0.000396	0.00128	CcSEcCtD
Morphine—Pruritus—Docetaxel—head and neck cancer	0.00039	0.00126	CcSEcCtD
Morphine—Diarrhoea—Docetaxel—head and neck cancer	0.000378	0.00122	CcSEcCtD
Morphine—Dizziness—Docetaxel—head and neck cancer	0.000365	0.00118	CcSEcCtD
Morphine—Vomiting—Docetaxel—head and neck cancer	0.000351	0.00113	CcSEcCtD
Morphine—Rash—Docetaxel—head and neck cancer	0.000348	0.00112	CcSEcCtD
Morphine—Dermatitis—Docetaxel—head and neck cancer	0.000348	0.00112	CcSEcCtD
Morphine—Headache—Docetaxel—head and neck cancer	0.000346	0.00111	CcSEcCtD
Morphine—Nausea—Docetaxel—head and neck cancer	0.000328	0.00106	CcSEcCtD
Morphine—UGT1A8—Metabolism—TYMS—head and neck cancer	0.000228	0.00109	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—GSTM1—head and neck cancer	0.000226	0.00108	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—HRAS—head and neck cancer	0.000225	0.00108	CbGpPWpGaD
Morphine—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000225	0.00107	CbGpPWpGaD
Morphine—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000222	0.00106	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—GRP—head and neck cancer	0.000218	0.00104	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—GPX1—head and neck cancer	0.000216	0.00103	CbGpPWpGaD
Morphine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000215	0.00103	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—NAT2—head and neck cancer	0.000214	0.00102	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—CYP1A1—head and neck cancer	0.000214	0.00102	CbGpPWpGaD
Morphine—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000213	0.00102	CbGpPWpGaD
Morphine—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00021	0.001	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—TYMS—head and neck cancer	0.0002	0.000954	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—TYMS—head and neck cancer	0.0002	0.000954	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—AKT1—head and neck cancer	0.000199	0.000949	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—GRP—head and neck cancer	0.000198	0.000947	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—GSTM1—head and neck cancer	0.000197	0.000943	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—GSTM1—head and neck cancer	0.000197	0.000943	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KISS1—head and neck cancer	0.000192	0.000917	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000191	0.000912	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—GPX1—head and neck cancer	0.000189	0.000903	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—GPX1—head and neck cancer	0.000189	0.000903	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—DPYD—head and neck cancer	0.000188	0.000897	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—UROD—head and neck cancer	0.000188	0.000896	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000187	0.000895	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—CYP1A1—head and neck cancer	0.000187	0.000894	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—CYP1A1—head and neck cancer	0.000187	0.000894	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000185	0.000882	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—IL2—head and neck cancer	0.000184	0.000879	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000183	0.000876	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000182	0.000871	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000182	0.00087	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—NAT2—head and neck cancer	0.000182	0.00087	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—YAP1—head and neck cancer	0.000178	0.000851	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000175	0.000836	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000173	0.000825	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KISS1—head and neck cancer	0.000168	0.000804	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—IL2—head and neck cancer	0.000167	0.000798	CbGpPWpGaD
Morphine—ABCB1—Metabolism—UROD—head and neck cancer	0.000163	0.000781	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	0.000162	0.000775	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—DPYD—head and neck cancer	0.00016	0.000762	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GRP—head and neck cancer	0.000158	0.000755	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—UROD—head and neck cancer	0.000154	0.000736	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT6—head and neck cancer	0.000153	0.000733	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—YAP1—head and neck cancer	0.000151	0.000724	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NAT2—head and neck cancer	0.000148	0.000707	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000145	0.000695	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NOTCH1—head and neck cancer	0.000143	0.000685	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KISS1—head and neck cancer	0.000142	0.000679	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GRP—head and neck cancer	0.000139	0.000662	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—YAP1—head and neck cancer	0.000136	0.000649	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT6—head and neck cancer	0.000135	0.000643	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—MAPK3—head and neck cancer	0.000134	0.000641	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—DPYD—head and neck cancer	0.00013	0.00062	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—MAPK1—head and neck cancer	0.000128	0.00061	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—EGFR—head and neck cancer	0.000128	0.00061	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PTGS2—head and neck cancer	0.000127	0.000608	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000125	0.000595	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—YAP1—head and neck cancer	0.000123	0.000588	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000122	0.000583	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000121	0.000577	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000119	0.000571	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000119	0.000569	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—YAP1—head and neck cancer	0.000119	0.000569	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GRP—head and neck cancer	0.000117	0.00056	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000114	0.000547	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT6—head and neck cancer	0.000114	0.000543	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000113	0.000539	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTGS2—head and neck cancer	0.000111	0.000532	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTGS2—head and neck cancer	0.000111	0.000532	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PTEN—head and neck cancer	0.000111	0.00053	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—PIK3CA—head and neck cancer	0.000111	0.00053	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—TYMS—head and neck cancer	0.000107	0.000511	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000107	0.000511	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GSTM1—head and neck cancer	0.000106	0.000505	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—HRAS—head and neck cancer	0.000103	0.00049	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000102	0.000485	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GPX1—head and neck cancer	0.000101	0.000484	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—UROD—head and neck cancer	0.000101	0.000481	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—YAP1—head and neck cancer	0.000101	0.000481	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CYP1A1—head and neck cancer	0.0001	0.000479	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AKT1—head and neck cancer	9.97e-05	0.000476	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL2—head and neck cancer	9.86e-05	0.000471	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTEN—head and neck cancer	9.7e-05	0.000464	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTEN—head and neck cancer	9.7e-05	0.000464	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCND1—head and neck cancer	9.62e-05	0.000459	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PTEN—head and neck cancer	9.28e-05	0.000443	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	9.18e-05	0.000439	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TYMS—head and neck cancer	9.09e-05	0.000434	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AKT1—head and neck cancer	9.06e-05	0.000433	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GSTM1—head and neck cancer	8.99e-05	0.000429	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	8.86e-05	0.000423	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GPX1—head and neck cancer	8.61e-05	0.000411	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP1A1—head and neck cancer	8.52e-05	0.000407	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—VEGFA—head and neck cancer	8.38e-05	0.000401	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—STAT3—head and neck cancer	8.3e-05	0.000397	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.27e-05	0.000395	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.19e-05	0.000391	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	8e-05	0.000382	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MAPK3—head and neck cancer	7.93e-05	0.000379	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—IL2—head and neck cancer	7.85e-05	0.000375	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PIK3CA—head and neck cancer	7.83e-05	0.000374	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NAT2—head and neck cancer	7.79e-05	0.000372	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	7.57e-05	0.000362	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MAPK1—head and neck cancer	7.55e-05	0.000361	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EGFR—head and neck cancer	7.54e-05	0.00036	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TYMS—head and neck cancer	7.39e-05	0.000353	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTM1—head and neck cancer	7.3e-05	0.000349	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	7.2e-05	0.000344	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	7.2e-05	0.000344	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL2—head and neck cancer	7.13e-05	0.000341	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GPX1—head and neck cancer	6.99e-05	0.000334	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP1A1—head and neck cancer	6.92e-05	0.000331	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL2—head and neck cancer	6.88e-05	0.000329	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PIK3CA—head and neck cancer	6.84e-05	0.000327	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PIK3CA—head and neck cancer	6.84e-05	0.000327	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—DPYD—head and neck cancer	6.83e-05	0.000326	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NAT2—head and neck cancer	6.78e-05	0.000324	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PIK3CA—head and neck cancer	6.55e-05	0.000313	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—YAP1—head and neck cancer	6.48e-05	0.00031	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AKT1—head and neck cancer	6.4e-05	0.000306	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NAT2—head and neck cancer	6.39e-05	0.000305	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—head and neck cancer	6.33e-05	0.000303	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL2—head and neck cancer	6.25e-05	0.000299	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	6.25e-05	0.000299	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NOTCH1—head and neck cancer	6.12e-05	0.000292	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HRAS—head and neck cancer	6.06e-05	0.000289	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.05e-05	0.000289	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—head and neck cancer	5.96e-05	0.000285	CbGpPWpGaD
Morphine—ABCB1—Metabolism—DPYD—head and neck cancer	5.95e-05	0.000284	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL2—head and neck cancer	5.82e-05	0.000278	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—MAPK3—head and neck cancer	5.73e-05	0.000274	CbGpPWpGaD
Morphine—ABCB1—Metabolism—YAP1—head and neck cancer	5.65e-05	0.00027	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—DPYD—head and neck cancer	5.61e-05	0.000268	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AKT1—head and neck cancer	5.59e-05	0.000267	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AKT1—head and neck cancer	5.59e-05	0.000267	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—MAPK1—head and neck cancer	5.45e-05	0.000261	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—head and neck cancer	5.45e-05	0.00026	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOTCH1—head and neck cancer	5.37e-05	0.000256	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—head and neck cancer	5.35e-05	0.000256	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—YAP1—head and neck cancer	5.32e-05	0.000254	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL2—head and neck cancer	5.28e-05	0.000252	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PIK3CA—head and neck cancer	5.21e-05	0.000249	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTEN—head and neck cancer	5.2e-05	0.000248	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.11e-05	0.000244	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—head and neck cancer	5.07e-05	0.000242	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—MAPK3—head and neck cancer	5.03e-05	0.00024	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.87e-05	0.000233	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—MAPK1—head and neck cancer	4.78e-05	0.000228	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—head and neck cancer	4.78e-05	0.000228	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—head and neck cancer	4.73e-05	0.000226	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—head and neck cancer	4.57e-05	0.000218	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOTCH1—head and neck cancer	4.53e-05	0.000217	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—head and neck cancer	4.42e-05	0.000211	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—head and neck cancer	4.38e-05	0.000209	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—head and neck cancer	4.26e-05	0.000203	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK3—head and neck cancer	4.25e-05	0.000203	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.25e-05	0.000203	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—head and neck cancer	4.21e-05	0.000201	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NAT2—head and neck cancer	4.18e-05	0.0002	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—head and neck cancer	4.15e-05	0.000198	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—head and neck cancer	4.12e-05	0.000197	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—head and neck cancer	4.1e-05	0.000196	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK1—head and neck cancer	4.04e-05	0.000193	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—head and neck cancer	4.04e-05	0.000193	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—head and neck cancer	3.96e-05	0.000189	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TYMS—head and neck cancer	3.89e-05	0.000186	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—head and neck cancer	3.87e-05	0.000185	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—head and neck cancer	3.86e-05	0.000184	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTM1—head and neck cancer	3.85e-05	0.000184	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—head and neck cancer	3.84e-05	0.000183	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—head and neck cancer	3.73e-05	0.000178	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—head and neck cancer	3.69e-05	0.000176	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GPX1—head and neck cancer	3.68e-05	0.000176	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—head and neck cancer	3.67e-05	0.000175	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—DPYD—head and neck cancer	3.67e-05	0.000175	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1A1—head and neck cancer	3.65e-05	0.000174	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—head and neck cancer	3.6e-05	0.000172	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—head and neck cancer	3.59e-05	0.000172	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—head and neck cancer	3.58e-05	0.000171	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—head and neck cancer	3.54e-05	0.000169	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—head and neck cancer	3.51e-05	0.000168	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—YAP1—head and neck cancer	3.48e-05	0.000166	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—head and neck cancer	3.47e-05	0.000166	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMS—head and neck cancer	3.39e-05	0.000162	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—head and neck cancer	3.39e-05	0.000162	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK3—head and neck cancer	3.39e-05	0.000162	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTM1—head and neck cancer	3.35e-05	0.00016	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—head and neck cancer	3.24e-05	0.000155	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK1—head and neck cancer	3.22e-05	0.000154	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—head and neck cancer	3.22e-05	0.000154	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GPX1—head and neck cancer	3.21e-05	0.000153	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMS—head and neck cancer	3.19e-05	0.000153	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.18e-05	0.000152	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.16e-05	0.000151	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—head and neck cancer	3.15e-05	0.000151	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—head and neck cancer	3.14e-05	0.00015	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—head and neck cancer	3.12e-05	0.000149	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—head and neck cancer	3.12e-05	0.000149	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—head and neck cancer	3.11e-05	0.000148	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—head and neck cancer	3.04e-05	0.000145	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GPX1—head and neck cancer	3.02e-05	0.000144	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3e-05	0.000143	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—head and neck cancer	3e-05	0.000143	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.99e-05	0.000143	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK3—head and neck cancer	2.97e-05	0.000142	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—head and neck cancer	2.94e-05	0.00014	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—head and neck cancer	2.86e-05	0.000137	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK1—head and neck cancer	2.82e-05	0.000135	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—head and neck cancer	2.82e-05	0.000135	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—head and neck cancer	2.8e-05	0.000134	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—head and neck cancer	2.7e-05	0.000129	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—head and neck cancer	2.65e-05	0.000127	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—head and neck cancer	2.63e-05	0.000125	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—head and neck cancer	2.59e-05	0.000124	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—head and neck cancer	2.55e-05	0.000122	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—head and neck cancer	2.53e-05	0.000121	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK3—head and neck cancer	2.51e-05	0.00012	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—head and neck cancer	2.45e-05	0.000117	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK1—head and neck cancer	2.39e-05	0.000114	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—head and neck cancer	2.39e-05	0.000114	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—head and neck cancer	2.37e-05	0.000113	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—head and neck cancer	2.28e-05	0.000109	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—head and neck cancer	2.27e-05	0.000108	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—head and neck cancer	2.17e-05	0.000104	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMS—head and neck cancer	2.09e-05	9.98e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—head and neck cancer	2.07e-05	9.9e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—head and neck cancer	2.07e-05	9.89e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.06e-05	9.86e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—head and neck cancer	2e-05	9.57e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—head and neck cancer	2e-05	9.57e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.98e-05	9.45e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.96e-05	9.35e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—head and neck cancer	1.92e-05	9.16e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—head and neck cancer	1.89e-05	9.03e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—head and neck cancer	1.89e-05	9.03e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.78e-05	8.5e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—head and neck cancer	1.69e-05	8.09e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—head and neck cancer	1.65e-05	7.87e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.55e-05	7.42e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.33e-05	6.37e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.16e-05	5.56e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.16e-05	5.55e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.1e-05	5.23e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—head and neck cancer	1.09e-05	5.21e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—head and neck cancer	1.01e-05	4.85e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—head and neck cancer	9.49e-06	4.54e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—head and neck cancer	8.95e-06	4.27e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	7.16e-06	3.42e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—head and neck cancer	5.85e-06	2.79e-05	CbGpPWpGaD
